Mostrando ítems 1-12 de 12

    • Activities and perceived risk of transmission and spread of sars-cov-2 among specialists and residents in a third level university hospital in Spain 

      Aranaz Andrés, Jesús María (1); McGee-Laso, Amaranta; Galán, Juan Carlos; Cantón, Rafael; Mira, José (International journal of environmental research and public health, 2021)
      This study aims to identify factors related with SARS-CoV-2 infection in physicians and internal residents during the SARS-CoV-2 pandemic at a tertiary hospital in Spain, through a cross-sectional descriptive perception ...
    • COVID-19 Comes 40 Years After AIDS - Any Lesson? 

      Soriano, Vicente (1); Barreiro, Pablo; Ramos, José M.; Eirós, José M.; Mendoza, Carmen de (AIDS Reviews, 06/2020)
      The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. In 1981, the first cases of AIDS were reported and wide diagnostic ...
    • Down’s syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach 

      Altable, Marcos; De la Serna Tuya, Juan Moisés (1) (Neurological sciences, 2021)
      Down syndrome (DS) is the most common genetic cause of learning difficulties and intellectual disabilities. DS patients often present with several congenital defects and chronic diseases, including immunity disorders. ...
    • Emergence and spread of b.1.1.7 lineage in primary care and clinical impact in the morbi-mortality among hospitalized patients in madrid, spain 

      Martínez-García, Laura; Espinel, Marco Antonio; Abreu, Melanie; González-Alba, José María; Gijón, Desirèe; McGee-Laso, Amaranta; Cantón, Rafael; Galán, Juan Carlos; Aranaz Andrés, Jesús María (1) (MDPI AG, 2021)
      In December 2020, UK authorities warned of the rapid spread of a new SARS-CoV-2 var-iant, belonging to the B.1.1.7 lineage, known as the Alpha variant. This variant is characterized by 17 mutations and 3 deletions. The ...
    • Estudio de algunos aspectos sobre las vacunas frente al SARS-CoV-2 

      San Miguel Hernández, Ángel (1); San Miguel Rodríguez, María (1) (Academia de Ciencias Medicas de Bilbao, 2021)
      Una vez que se demuestra que una vacuna es segura y eficaz, deben ser aprobadas por los organismos nacionales de reglamentación y fabricarse con arreglo a normas precisas y distribuirse. La OMS está colaborando con todos ...
    • Main differences between the first and second waves of COVID-19 in Madrid, Spain 

      Soriano, Vicente (1); Ganado-Pinilla, Pilar (1); Sánchez-Santos, Miguel (1); Gómez-Gallego, Felix (1); Barreiro, Pablo; de Mendoza, Carmen; Corral, Octavio Jorge (1) (International journal of infectious diseases, 2021)
      Background: The emergence and rapid global spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) represents a major challenge to health services, and has disrupted social and economic activities worldwide. ...
    • New sars-cov-2 variants challenge vaccines protection 

      Soriano, Vicente (1); Fernandez-Montero, José V. (AIDS Reviews, 2021)
      By the end of February 2021, roughly 115 million people worldwide had been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and more than 2.5 million had died. Uneasily, the coronavirus disease ...
    • Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets 

      Altable, Marcos; De la Serna Tuya, Juan Moisés (1) (Virus research, 2021)
      Background: There is a marked discrepancy between SARS-CoV-2 seroprevalence and COVID-19 cases and deaths in Africa. Main: SARS-CoV-2 stimulates humoral and cellular immunity systems, as well as mitogen-activated protein ...
    • SARS-CoV-2: A Promising Path in Salivary Diagnosis 

      Leci Fernandes, Larissa; Borges, Leandro; Bordallo Pacheco, Valeria; Bernardes, Alessandra; Rosa Ribeiro, Rafaela; Jiménez, Manuel (1); Heller, Debora (Open Dentistry Journal, 2020)
      Since March 2020, the World Health Organization (WHO) established the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) as ...
    • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis 

      Thompson, Hayley A; Mousa, Andria; Dighe, Amy; Fu, Han; Arnedo-Pena, Alberto; Barrett, Peter; Bellido-Blasco, Juan; Bi, Qifang; Caputi, Antonio; Chaw, Liling; De Maria, Luigi; Hoffmann, Matthias; Mahapure, Kiran; Ng, Kangqi; Raghuram, Jagadesan; Singh, Gurpreet (1); Soman, Biju; Valent, Francesca; Vimercati, Luigi; Wee, Liang En; Wong, Justin; Ghani, Azra C; Ferguson, Neil M. (Oxford University Press, 2021)
      Background: Understanding the drivers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is crucial for control policies, but evidence of transmission rates in different settings remains limited. ...
    • The Impact of COVID-19 Management Policies Tailored to Airborne SARS-CoV-2 Transmission: Policy Analysis (vol 7, e20699, 2021) 

      Telles, Charles Roberto; Roy, Archisman Archisman; Ajmal, Mohammad Rehan; Mustafa, Syed Khalid; Ahmad, Mohammad Ayaz; De la Serna Tuya, Juan Moisés (1); Frigo, Elisandro Pires; Hernández Rosales, Manuel (JMIR public health and surveillance, 2021)
      In “The Impact of COVID-19 Management Policies Tailored to Airborne SARS-CoV-2 Transmission: Policy Analysis” (JMIR Public Health Surveill 2021;7(4):e20699), the authors noted one error. The academic degree of author ...
    • The Importance of Understanding the Stages of COVID-19 in Treatment and Trials 

      Griffin, Daniel O.; Brennan-Rieder, Denise; Ngo, Binh; Kory, Pierre; Confalonieri, Marco; Shapiro, Leland; Iglesias, Jose; Dube, Michael; Nanda, Neha; In, Gino K.; Arkfeld, Daniel; Chaudhary, Preet; Campese, Vito M.; Hanna, Diana L.; Sawcer, David; Ehresmann, Glenn; Peng, David; Smorgorzewski, Miroslaw; Amstrong, April; Vinjevoll, Eivind H.; Dasgupta, Rajkumar; Sattler, Fred R.; Mussini, Cristina; Mitjà, Oriol; Soriano, Vicente (1); Peschanski, Nicolas; Hayem, Gilles; Piccirillo, Maria Carmela; Lobo-Ferreira, António; B. Rivero, Iraldo; Hung, Ivan F. H.; Rendell, Marc; Ditmore, Stephen; Varon, Joseph; Marik, Paul (AIDS reviews, 2021)
      COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment ...